Hearing and vision rehabilitation for people with dementia in five European countries (SENSE-Cog): a randomised controlled trialIracema Leroi, Éric Frison, David Reeves et al.|The Lancet Healthy Longevity|2024Cited by 16
Emerging disease modifying therapies for older adults with Alzheimer disease: perspectives from the EuGMS special interest group in dementiaAdam H. Dyer, Verena C. Tatzer, Helena Dolphin et al.|European Geriatric Medicine|2023Cited by 9
Navigating the future of Alzheimer’s care in Ireland - a service model for disease-modifying therapies in small and medium-sized healthcare systemsIracema Leroi, Suzanne Timmons, Helena Dolphin et al.|BMC Health Services Research|2024Cited by 9
Differences in identification of patients’ deterioration may hamper the success of clinical escalation protocolsAshley J.R. De Bie, Kerian O’Mahony, Christian P Subbe et al.|QJM|2019Cited by 8
Dissonance in the face of Alzheimer's disease breakthroughs: clinician and lay stakeholder acceptance, concerns and willingness to pay for emerging disease-modifying therapiesIrina Kinchin, Iracema Leroi, Sharon Walsh et al.|The British Journal of Psychiatry|2024Cited by 7